StockWatch
·

BRITANNIA INDUSTRIES LTD. Q1 FY27 Results

BRITANNIAQ1 FY27 Results
Filing
Result:Good· Market: FlatMargin expansion

Outlook: Cautiously Optimistic · Guidance: None

MetricValueQ4 FY26Q1 FY26
Revenue5.0K Cr6.0%8.2%
Total Income5.1K Cr6.0%8.2%
Expenditure4.3K Cr7.4%7.3%
PBT799.14 Cr0.7%13.2%
Net Profit593.38 Cr12.7%14.1%
OPM16.80%1.27pp0.42pp
NPM11.72%2.52pp0.60pp
EPS24.5512.8%13.6%
View full financials

Revenue grew a healthy 8.2% and adjusted PAT grew 14.1% on margin expansion (OPM 16.8% vs 16.4%, NPM 11.7% vs 11.1%), a solid above-average FMCG quarter without one-off items, though revenue growth alone isn't a standout beat.

BRITANNIA · Q1 FY27 · THE VERDICT

Revenue growth overstated; cost inflation only half-mitigated

Management claimed 9.5% revenue growth but delivered 8.2% YoY, yet PAT grew 14.1% and margins held at 11.7% NPM. The call explains the gap: operational leverage is working, but input-cost headwinds are only 50% offset—margin expansion is capped.

16 Aug 2026 · 6 min read
Revenue

₹5,000 Cr

8.2% YoY (vs mgmt claim 9.5%)

PAT

₹593 Cr

+14.1% YoY; strong operating leverage

NPM

11.7%

Stable vs prior year

OPM

16.8%

Above 5-yr avg of 15.3%

Britannia delivered solid profitability—PAT up 14.1%, margins stable at 11.7% NPM—but the revenue story is more complicated. Management claimed 9.5% growth in the call. The result shows 8.2% YoY. That 130-basis-point gap is the first thing analysts noticed, and the call reveals why: a quarter marked by shrinkflation as the primary pricing lever and only 50% of input-cost inflation mitigated. Operating leverage is real, but margin expansion is capped.

Where the growth claim fell short

In the opening remarks, management cited revenue of ₹4,964 Cr on a console basis, which on an annual basis represents 9.5% growth. The delivered consolidated result: ₹5,000 Cr, which equates to 8.2% YoY. The gap widens when you dig into the claim of a "mid-teens June exit." That assertion is inconsistent with a 9.5% quarter-average growth rate—it implies April-May softness that June pulled up. Analysts (Mihir Shah at Nomura, Arnab Mitra at Goldman Sachs) pressed hard on this point. Management's response: dual pricing was resolved by June, retailers who had switched temporarily returned in strong numbers, and June throughput was clean (no destocking bounce). That explanation holds up for the June rebound, but it doesn't reconcile with the mid-teens claim. The honest read: April-May were softer due to dual pricing disruption, June recovered post-resolution, but the quarter-average growth landed at 8.2%, not the 9.5% headline.

Management claims vs. actual delivered

Revenue growth 9.5% YoY (console basis)

Delivered 8.2% YoY consolidated (₹5,000 Cr)

Overstated by 130 bps

Mid-teens June growth exit

9.5% quarter avg; June recovery post-dual pricing, but inconsistent with mid-teens monthly claim

Contradicted

9% volume + 1% pricing = ~10% nominal

Supports 8.2% delivered (mix effect, prior-year base reconcile)

Supported

PAT growth 13.6% YoY

Delivered 14.1% YoY (₹593 Cr)

Supported

Mitigated 50% of input cost inflation via price/shrinkflation

LPG 2.5x Apr-May spike, sugar +₹7/kg, palm +20%; explicitly stated 50% mitigation only

Supported

Croissant at ₹100 Cr ARR growing 30%

Actually ₹200 Cr ARR (doubled), still 30%+ growth

Understated

Cost inflation: only half the battle

The margin resilience in this quarter—11.7% NPM, 16.8% OPM (above the 5-year average of 15.3%)—is impressive given the commodity tailwinds reversed hard. LPG and PNG surged 2.5x in April-May, sugar prices rose ₹7 per kilogram in just the last 2-3 weeks of the quarter, and palm oil jumped 20% to ₹140. This is real input pressure. Yet Britannia held margin. How? Shrinkflation (lower pack weight, same price of ₹5 or ₹10) and a 1% pricing realization that management says it expects to ramp to +1.5–2% in Q2 as machinery changes take effect. The problem: management explicitly stated it has mitigated only 50% of the input cost inflation. The other 50% is being absorbed in the cost of goods sold. If commodity costs stay elevated—and the call gives no reason to expect them to fall sharply—the company has no more room to absorb margin compression. Operating leverage will plateau.

The inflation on LPG was very real...really went up about 2.5x, that has come down. From an index point of view, it is at about 1.5x, but it is still far more than what we had in February.

Operating leverage working—for now

PAT grew 14.1%, well ahead of the 8.2% revenue growth. That 560-basis-point spread comes from three sources: (1) operating leverage on fixed costs, (2) favorable tax/other income, and (3) the phantom stock benefit collapsing from ₹52 Cr in the prior year to ₹1 Cr this quarter (a one-time headwind to YoY comps, but neutral operationally). The core story is that cost discipline (shrinkflation, efficiency programs, 16% renewable energy increase at plants) is delivering margin stability despite only 50% input-cost offset. This is real execution. But it's not expansion—the NPM stayed flat at 11.7% vs prior year. Once input costs are 50% mitigated, further margin gains depend entirely on pricing (+1.5–2% ramp in Q2+) and volume holding. If either slips, or if commodity costs stay elevated, the PAT-to-revenue growth spread will normalize.

What changed on this call

Shifts from prior quarter
  • Dual pricing resolved (upgrade)

  • General Trade recovery post-resolution; key states & other states both accelerating (upgrade)

  • Input cost inflation persists (LPG 1.5x, sugar +₹7/kg, palm +20%)—only 50% mitigated (downgrade)

  • Shrinkflation is primary pricing lever; +1.5–2% pricing expected Q2+ (strategic shift)

  • Croissant ₹200 Cr ARR at 30%+ growth; was understated as ₹100 Cr (upgrade)

  • Adjacency portfolio (cake, rusk, wafers, dairy) all double-digit growth (upgrade)

  • E-commerce 6% of sales, 80–85% via quick-commerce, double-digit growth (upgrade)

  • International headwinds (Saudi, NA) ongoing; new head in place 2 months (neutral/execution risk)

The adjacency play is real—but represents a shift in earnings mix

Britannia's core biscuit franchise is steady, but the growth momentum is coming from elsewhere. Croissant (croissants, not the traditional biscuit) is now a ₹200 Cr annualized revenue run-rate, growing 30%+. Cake, rusk, and wafers are all growing double-digits. Dairy (Milk Bikis, Laughing Cow cheese slices, Sattvam ghee) is growing double-digits. The non-biscuit portfolio is approaching 25% of sales. This is portfolio diversification in action, and it's accretive to margins (these are higher-priced, higher-margin categories). But it also means the biscuit core is slowing. E-commerce is another bright spot: 6% of total sales, but growing double-digits, with 80–85% flowing through quick-commerce. This is a higher-margin, faster-growing channel, but it's still small relative to the General Trade base (which is 60% of sales at fixed INR 5/10 price points). The earnings mix is shifting toward higher-margin adjacencies, which is positive for profitability—but it's a different story than biscuit-driven growth.

Bull-bear ledger

What's working / what's not
  • PAT grew 14.1% YoY; operating leverage evident despite cost headwinds

  • Margins stable at 11.7% NPM, 16.8% OPM (above 5-yr avg)—cost discipline real

  • Dual pricing resolved; General Trade recovered post-disruption

  • Adjacency momentum (Croissant 30%+, dairy/cake/rusk double-digit) driving earnings mix

  • E-commerce 6% of sales, double-digit growth; 80–85% via quick-commerce (high-margin channel)

  • Revenue growth 8.2% YoY vs claimed 9.5%—130-bps credibility gap

  • Only 50% of input cost inflation mitigated; other 50% absorbed in P&L—margin expansion capped

  • Limited pricing power in GT (60% at INR 5/10 fixed price); shrinkflation is low-quality growth lever

  • International headwinds (Saudi, NA) unresolved; new leadership 2 months in place

  • No numeric FY27 guidance; 'good year' and 'virtuous triangle' are vague—suggests mgmt uncertainty

  • Phantom stock benefit collapsed from ₹52 Cr to ₹1 Cr; one-time headwind to YoY comps

The debate

Risks ranked by severity

What should concern a holder

Input cost inflation only 50% mitigated; other half absorbed in P&L

High

LPG 1.5x, sugar +₹7/kg, palm +20% are real. If sustained, margin expansion is over. Further compression will hit operating profit directly. Management has exhausted the buffer to absorb cost headwinds without taking volume loss or eroding margins further.

Limited pricing power in General Trade (60% of sales at fixed INR 5/10 price points)

High

Shrinkflation (lower weight, same price) is the primary lever, not value pricing. Consumer elasticity is muted. If competition intensifies or consumers notice pack shrinkage, volume could compress. GT is the earnings base; limited pricing power there caps upside.

Revenue growth overstated (8.2% actual vs 9.5% claimed); analyst credibility pushback

Medium

130-bps gap signals either management overstating momentum or reluctance to admit Apr-May softness. Analysts pressed hard; no satisfactory explanation erodes confidence in forward guidance. If June exit was not truly 'mid-teens', momentum narrative is weaker than claimed.

International business headwinds (Saudi, North America) unresolved; new head 2 months in

Medium

4 months of disruption in large markets. New leadership is early stage; execution risk remains. Africa (Kenya) is positive offset, but international base is still pressured. No return-to-growth timeline given.

No numeric FY27 guidance; vague on health/wellness platform timeline

Medium

'Good year' and 'virtuous triangle' are undefined. No specific revenue/margin/growth targets for FY27. New category launches are 'in development' with no timeline. Management transparency on forward visibility is low.

Phantom stock charge collapsed from ₹52 Cr to ₹1 Cr; one-time benefit to YoY comps is gone

Low

One-time item. Q1 FY27 benefits from low phantom stock (₹1 Cr vs ₹52 Cr prior year). Q2+ comparison will normalize. Not a core operational issue, but a tailwind that won't repeat.

How the street is positioned

Price action held post-result. The stock popped +1.96% on day 1 of the result announcement and extended the move to +3.9% by day 5. The pop held and didn't fade—a positive signal. The market confirmed the operational execution: margins held, PAT grew 14.1%, adjacency momentum is real. Initial skepticism on the revenue-growth claim and cost headwinds did not translate into a post-result selloff. This suggests the street had already priced in the concerns, or domestic institutions are more convinced by the operational story than FII.

Valuation and trend. At ₹5,558, the stock is 11.4% below its all-time high (₹6,271) and trading above both the 20-day (₹5,496) and 50-day (₹5,352) moving averages, but below the 200-day (₹5,687). The trend is neutral; the stock is in a consolidation range between support and the 200-day. RSI of 60 is neutral. Volume is normal. The stock is not cheap on a drawdown basis; it's holding the highs relative to the quarter.

FII and DII flows. FII ownership fell 2.23 percentage points to 13.40% in Q1 FY27 (from 15.63% in Q4 FY26)—a trim on strength. DII ownership rose 2.06 percentage points to 20.93% (from 18.87%)—accumulation. Promoter ownership is flat at 50.55%. The FII trim is notable: they're exiting a stock that just reported solid profitability and held margins. This suggests caution about forward earnings despite operational execution—likely driven by the known cost headwinds (only 50% mitigated) and vague FY27 guidance. DII accumulation suggests domestic institutions see value. Mixed positioning, but the fact the pop held despite FII exit indicates retail and domestic institutions are supporting the narrative.

Reconciliation. The post-result pop holding up despite FII trimming means the operational execution (PAT growth, margin stability, adjacency momentum) is being credited by the market, especially by domestic players. But FII's trim-on-strength is a warning: they're not convinced the margin gains are sustainable given the cost pressures. This is a reasonable disagreement: Britannia delivered a good quarter operationally, but forward earnings growth depends on Q2+ pricing execution and commodity moderation—both uncertain. Fair value here; not an obvious buy, not an obvious sell.

What to watch next

Catalysts and inflection points for Q2 and beyond
  • 1 · Q2 FY27 pricing realization (+1.5–2% expected vs Q1's 1%)

    This is the crucial test of margin sustainability. Management expects pricing to ramp as shrinkflation machinery changes roll out. If realized, the profit story stabilizes. If not, PAT growth will decelerate and re-converge to revenue growth (8–9%). Watch the Q2 OPM and NPM margins; they will signal whether pricing is sticking.

  • 2 · Q2 base effect (September FY26 GST transition impact)

    September of FY26 saw GST transition buying confusion, creating an easy comp for Q2 FY27. If organic growth accelerates off that low base, it signals genuine demand momentum. If growth stays flat or slows, the demand environment is weaker than the 'positive' tone on the call suggests. Monitor the monthly trend within Q2 (Jul/Aug vs Sep).

  • 3 · Health/wellness platform launch and protein category timeline

    Management cited 'internal teams working' and 'you have to wait and watch.' No concrete timeline given. This is a multi-year growth pillar in the narrative, but it's vague. When this launches, and whether it gains traction, will either validate the portfolio diversification story or signal execution delays. Expect color on this in subsequent calls.

  • 4 · International business stabilization (Saudi, North America recovery)

    New head of international business joined 2 months ago. The call acknowledged 4 months of disruption in these large markets. Sequentially improving vs returning to growth are different stories. If Q2 shows return to growth (not just stabilization), the upside case reopens. If still pressured, the growth headwind persists.

The single number to track from here

Organic PAT growth in Q2 FY27. Reported PAT growth (headline) may vary based on phantom stock and other items. But organic PAT growth—operating profit less normalized tax, adjusted for one-time items—is the signal of whether margin sustainability is real. If Q2 organic PAT grows 10%+ (pricing +1.5–2% sticks, volume holds, costs contained), the margin story is confirmed. If it's flat or negative YoY (costs overrun pricing, volume slips), the hold-the-line scenario is confirmed and multiples will compress. This single number resolves the debate.

Britannia delivered a solid operational quarter—profitability ahead of revenue growth, margins held, adjacency momentum is real, e-commerce accelerating. But the underlying story is constrained: revenue growth is slowing (8.2% YoY, vs claimed 9.5%), and margin expansion is capped by unmitigated cost inflation (only 50% offset, 50% absorbed). This is not a step-change. It's steady, disciplined execution under pressure.

The company is managing well—shrinkflation as a growth lever, efficiency programs keeping costs down, adjacency portfolio diversification driving earnings mix upward. But the room for further margin gains is limited. FY27 is shaping up as a hold-the-line year, not a growth acceleration.

Holders should focus on Q2 pricing execution. If management delivers +1.5–2% realization while holding volume, the margin story stabilizes and the stock can re-rate higher. If pricing slips or volume absorbs it, PAT growth will decelerate. Fair value here; not an obvious buy, not an obvious sell. The debate resolves in Q2 and Q3 on the sustainability of pricing and the international recovery trajectory.

Informational and educational content only. Not investment advice.